Biography

Gilbert Achermann (Born 1964, Swiss citizen) has served as Chair of the Board of Directors of Sonova Holding AG since June 2025. 

Gilbert Achermann served as Chair of the Board of Directors of Straumann Group from 2010 to 2024. Prior to this, he held the roles of Chief Financial Officer and subsequently Chief Executive Officer at Straumann Group, where he spent more than 12 years and played a key role in the company’s development into a global leader in the dental industry. In 2020, he was elected to the Board of Directors of Ypsomed Group and became its Chair in 2022. In the same year, he joined the Board of Directors of Unilabs S.A. and was appointed Chair of the Board in 2023. Since 2019, Gilbert Achermann has been a member of the Foundation Board and Supervisory Board of IMD in Lausanne, Switzerland, and was elected Vice Chair in 2026. He has also been a member of the Management Board of Swiss Medtech since 2020 and has served as its Vice President since 2024. From 2012 to 2024, he was a member of the Board of Directors of Julius Baer Group.

Gilbert Achermann holds a degree in Business Administration from the University of Applied Sciences in St. Gallen, Switzerland, and an Executive MBA from IMD Lausanne, Switzerland.

Outside mandates

Listed companies:

• Chair of the Board of Directors of Ypsomed Group

Other mandates:

• Chair of the Board of Directors of Unilabs S.A.
• Member of the Board Greenteg AG
• Member of the Management Board and Vice President of the Swiss Medtech Association
• Supervisory Board of IMD – International Institute for Management Development in Lausanne

Holdings as of 31.03.2025

• Shares: 9’771
• Restricted Shares¹⁾: 501
   

1) These shares are subject to a restriction period which varies from June 1, 2025 to June 1, 2030 depending on the grant date. For further details see also Note 7.4 in the consolidated financial statements.